Symvivo Corporation

Burnaby, Canada

Symvivo Corporation is a clinical-stage biotechnology company that develops DNA vaccines for genetic and life-threatening diseases.

$650K raised

May 2022

Grant

Biotechnology Health Care Health Diagnostics Medical

Top Investors

Pacific Economic Development Canada

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Symvivo Corporation

How much funding has Symvivo Corporation raised?

Symvivo Corporation has raised $650K in total funding. The most recent round was Grant. The last funding was announced in May 2022.

Who are Symvivo Corporation's investors?

Symvivo Corporation's investors include Pacific Economic Development Canada.

Where is Symvivo Corporation headquartered?

Symvivo Corporation is headquartered in Burnaby, Canada.

What does Symvivo Corporation do?

Symvivo Corporation is a clinical-stage biotechnology company that develops DNA vaccines for genetic and life-threatening diseases.

What stage is Symvivo Corporation at?

Symvivo Corporation is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 31, 2022.

MLA

"Symvivo Corporation — Funding & Investors." VCBacked, May 31, 2022, https://www.vcbacked.co/company/symvivo-corporation. Accessed July 2, 2026.

APA

VCBacked. (2022). Symvivo Corporation — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/symvivo-corporation

Wikipedia (cite web)

{{cite web |title=Symvivo Corporation — Funding & Investors |url=https://www.vcbacked.co/company/symvivo-corporation |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 31, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K